Companies: 10,638     total market cap: โ‚ฌ116.357 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novavax
NVAX
#5751
Rank
โ‚ฌ0.96 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
5,93ย โ‚ฌ
Share price
0.73%
Change (1 day)
-29.86%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for Novavax (NVAX)

Revenue in 2025 (TTM): โ‚ฌ0.92 Billion

According to Novavax's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.87 Billion. In 2024 the company made a revenue of โ‚ฌ0.65 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.62 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.92 B41.38%
2024 โ‚ฌ0.65 B4.5%
2023 โ‚ฌ0.62 B-51.71%
2022 โ‚ฌ1.29 B28.34%
2021 โ‚ฌ1.01 B161.77%
2020 โ‚ฌ0.38 B2221.07%
2019 โ‚ฌ16.65 M-44.42%
2018 โ‚ฌ29.97 M15.35%
2017 โ‚ฌ25.98 M78.01%
2016 โ‚ฌ14.59 M-55.98%
2015 โ‚ฌ33.15 M31.52%
2014 โ‚ฌ25.2 M66.46%
2013 โ‚ฌ15.14 M-9.26%
2012 โ‚ฌ16.68 M47.56%
2011 โ‚ฌ11.31 M4285.99%
2010 โ‚ฌ0.25 M13.68%
2009 โ‚ฌ0.22 M-70.19%
2008 โ‚ฌ0.76 M-14.84%
2007 โ‚ฌ0.89 M-74.82%
2006 โ‚ฌ3.54 M-43.09%
2005 โ‚ฌ6.23 M-5.2%
2004 โ‚ฌ6.57 M-29.73%
2003 โ‚ฌ9.36 M-31.1%
2002 โ‚ฌ13.58 M-50.14%
2001 โ‚ฌ27.25 M937.22%
2000 โ‚ฌ2.62 M120.31%
1999 โ‚ฌ1.19 M102.16%
1998 โ‚ฌ0.58 M16.67%
1997 โ‚ฌ0.5 M100%
1996 โ‚ฌ0.25 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agenus
AGEN
โ‚ฌ91.75 M-89.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚ฌ2.07 B 135.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.64 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.51 B-41.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ49.92 B 5,574.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ53.92 B 6,029.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ48.41 B 5,403.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ36.37 B 4,034.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
โ‚ฌ2.23 M-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com